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Cardiac evaluation in hypotension-prone and hypotension- modialysis-induced hypotension is multifactorial, rang-
resistant hemodialysis patients. ing from primarily patient-related factors, such as
Background. Hypotension during hemodialysis occurs fre-
underlying coronary artery disease and diastolic and sys-quently, but the precise mechanism remains unclear. In this
tolic dysfunction [2], to more hemodialysis related fac-study, the presence of myocardial ischemia and myocardial
contractile reserve during infusions of the b-adrenergic recep- tors, such as speed and amount of ultrafiltration and
tor agonist dobutamine was assessed by means of dobutamine- used dialysate [3].
atropine stress echocardiography (DSE) in hypotension-prone
Atherosclerosis occurs frequently in patients with re-(HP) and hypotension-resistant (HR) hemodialysis patients.
nal insufficiency. Cardiovascular disease is reported toMethods. Eighteen HP patients (age 53 6 6 years) were
compared with 18 HR patients (age 53 6 3 years), matched cause approximately 50% of deaths among patients with
with respect to the duration of hemodialysis and cardiovascular end-stage renal failure [2]. Factors causally related to
history. New wall abnormalities during dobutamine stress re-
this high frequency of coronary artery disease are hyper-flect the presence of myocardial ischemia, whereas the increase
tension, hypertriglyceridemia, and hypercholesterolemiain stroke index and cardiac index reflects myocardial contractile
reserve. [4]. More recently, hyperhomocysteinemia, endothelial
Results. Wall motion score at rest (1.42 6 0.53 vs. 1.44 6 dysfunction, and increased oxidant stress have been iden-0.57) and dobutamine-induced new wall motion abnormalities
tified as additional cardiovascular risk factors [5].(4 vs. 3 patients) between HP and HR patients were similar,
but responses of cardiac index, stroke index, and systolic blood Assessment of left ventricular function and the pres-
pressure to do butamine between the two groups were differ- ence of coronary artery disease can be performed by
ent. Not withstanding a similar cardiac index at rest (2.4 6 1.1 dobutamine-atropine stress echocardiography (DSE).liter/min/m2 in HP and 2.8 6 1.2 liter/min/m2 in HR patients),
At low infusion rates (10 mg/kg/min), dobutamine pre-dobutamine-induced increments in the cardiac index were con-
siderably smaller in the former (0.8 6 1.3 liter/min/m2) than dominantly exerts an inotropic effect, whereas at higher
in the latter patients (2.3 6 1.6 liter/min/m2, P 5 0.002), pre- infusion rates, the chronotropic effect prevails. Hence,
dominantly because of a progressive decrease in the stroke
with the lower infusion rates of dobutamine, informationindex in the HP patients.
about myocardial contractile reserve is obtainable,Conclusion. Impaired myocardial contractile reserve rather
than ischemia is predominant in HP patients. This impaired whereas with higher infusion rates information about the
myocardial contractile reserve may play a role in the develop- presence of ischemia is obtainable. Ischemia is detected
ment of hemodialysis-induced hypotension.
by DSE as new wall motion abnormalities (NWMAs).
The accuracy of DSE for diagnosing coronary artery
disease has been confirmed in a large number of patients,Hypotension during hemodialysis occurs in approxi-
including patients with end-stage renal disease and sig-mately 30% of patients [1]. The pathophysiology of he-
nificant coronary artery disease as diagnosed by coronary
angiography [6–8].Key words: dialysis hypotension, myocardial cardiac reserve, ischemic
The aim of this study was to investigate whether hypo-renal disease, end-stage renal failure.
tension-prone (HP) and hypotension-resistant (HR) he-
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Table 1. Clinical characteristics of hypotension-resistant (HR) and was measured just prior the DSE for a period of five
hypotension-prone (HP) hemodialysis patients
minutes, and the values were averaged. Via the same
HR HP P value catheter, a blood sample was taken for measurement of
Number 18 18 NS the concentrations of atrial natriuretic peptide (ANP)
Age6mean 53 66 53 63 NS and norepinephrine (NOR) in plasma.
Sex male/female 15/3 10/8 NS
BSA m2 1.73 1.76 NS
Dobutamine-atropine stress echocardiographyDuration of hemodialysis years 3.162.1 3.5 61.9 NS
Hematocrit liter/liter 0.3160.06 0.32 60.05 NS Dobutamine-atropine stress echocardiography was
History of myocardial infarction 14 8 NS
performed as previously described [9]. In short, after aAngina pectoris N 8 10 NS
Diabetes mellitus N 2 1 NS two-dimensional resting echocardiographic examina-
ACE-inhibitors N 9 5 NS tion, dobutamine was infused intravenously. Dobut-
Norepinephrine pg/ml 4296209 381 6174 NS
amine infusion was started at 5 mg/kg/min for five min-Atrial natriuretic peptide pg/ml 8176491 809 6429 NS
Beta blocker treatment N 12 6 0.04 utes followed by 10 mg/kg/min for five minutes. After this
Rest wall motion score 1.42 60.56 1.40 60.52 NS “low-dose” stage, the dobutamine infusion was increased
Abbreviations are: BSA, body surface area; NS, not significant. every three minutes by 10 mg/kg/min to a maximum of
40 mg/kg/min, unless a test endpoint was reached. Test
endpoints were (1) achievement of a target heart rate
(maximum heart rate adjusted for age and gender), (2)
METHODS
signs of myocardial ischemia, and (3) side effects. If one
Patients of the test endpoints was not achieved, despite the maxi-
mal dobutamine infusion rate, atropine was added intra-Eighteen HP dialysis patients were studied. Hypoten-
sion prone was defined as (a) symptoms of hypotension venously to a maximum of 2 mg. Blood pressure and
heart rate were measured at baseline and at the end of(dizziness and syncope) during hemodialysis during at
least one third of dialysis sessions for more than one every dose step by a semi-automatic oscillometric blood
pressure monitor (Accutorr 2, Datascope; Datascopeyear in combination with a reduction in systolic blood
pressure by at least 25% and/or a systolic blood pressure Corp., Paramus, NJ, USA). Echocardiographic images
were recorded from standard parasternal long- andbelow 100 mm Hg, and (b) a requirement of intravenous
inotropic pressor agents and/or fluid infusion to avoid short-axis and apical two- and four-chamber views. Im-
ages were monitored continuously and recorded at thehypotension.
Relevant clinical characteristics of the patients are end of each dose step. The echocardiographic images
were analyzed off-line for the presence of wall motiongiven in Table 1. Eighteen HR dialysis patients served
as a control group. These patients were matched with abnormalities and to obtain values of stroke volume.
Two experienced investigators (D.P. and R.R.) per-the HP group with respect to age, gender, cardiovascular
history and symptoms, presence of diabetes mellitus, and formed analyses, unaware of the clinical condition of the
patients.duration of hemodialysis (Table 1). b-Blockers were
more frequently used by the HR than by the HP patients. Wall motion analysis. The left ventricular wall was
divided into 16 segments, and wall motion was scoredAll subjects were dialyzed three times weekly using a
bicarbonate containing dialysate and artificial kidneys by using a five-point scale with values indicating: 1 5
normal; 2 5 mild hypokinetic; 3 5 severe hypokinetic;with biocompatible membranes (Gambrane, hemo-
phane, or polysulfone). All patients were informed about 4 5 akinetic; and 5 5 dyskinetic. For each patient, a wall
motion score index (total score divided by the number ofthe aim and procedures of the study. If they consented
verbally to participate, an appointment to perform a segments) was calculated at rest, at low dose dobutamine
infusion, and at peak dose dobutamine infusion. Reduc-DSE was made. In each patient, the DSE was performed
one day before a hemodialysis session. If patients were tion of wall thickening and new wall motion abnormali-
ties (NWMAs), with the exception of the transition ofusing b-blockers or other antihypertensive medications,
this treatment was discontinued on the day DSE was akinesia to dyskinesia, during the stress test is considered
to be hallmark of ischemia. The transition of akinesiaperformed. The local Ethics Committee approved the
study protocol. to dyskinesia does not reflect ischemia, but is a mechani-
cally induced phenomenon [10].
Central venous pressure measurement Stroke volume. Stroke volume was measured at rest,
at low dose, and at peak dose dobutamine by means ofMeasurement of central venous pressure (CVP) was
performed in nine of the HP and in eight of the HR the biplane discs method. The volume of the left ventricle
was calculated from the apical two- and four-chamberpatients. For this purpose, a small catheter with a length
of 12 and a diameter of 0.6 mm was inserted in the views using a modification of Simpson’s rule [11]. The
principle of Simpson’s rule is to divide the left ventricleinternal jugular vein using the Seldinger technique. CVP
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Table 2. Results of dobutamine stress echocardiography ininto slices of known thickness. The volume of the ventri-
hypotension-prone (HP) and hypotension-resistant (HR)
cle is then equal to the sum of the volume of the slices. hemodialysis patients
Two- and four-chamber apical views were recorded and
HR HP P valuestored. The endocardial borders of these views were
Patients with rest wall motiondigitally traced at end diastole and end systole. Each
abnormalities N 11 11 NS
projection was divided in 20 sections along the long axis. E/A velocity ratio 0.81 60.31 0.7960.20 0.86
Test endpointsThen the volumes were computed. Stroke volume was
Target heart rate 16 16 0.3calculated as the difference between end-diastolic and
Severe angina 1 1 0.7
end-systolic volume. The stroke volume as determined Side-effects 1 1 0.7
Atropine addition 9 5 0.2by the two investigators was averaged. Cardiac output
NWMAs 4 3 1.0was calculated as stroke volume times heart rate.
Hypotension during DSE 2 4 0.4
Pulse-wave Doppler. Pulse-wave Doppler studies were Angina during DSE 4 3 0.7
ST changes during DSE 7 6 1.0recorded from the apical four-chamber view, with the
Doppler sampler positioned just within the inflow por- Abbreviations are: NWMAs, new wall motion abnormalities; DSE, dobut-
amine stress echocardiography; E/A, early-rapid ventricular filling/atrial-assistedtion of the left ventricle, midway between the annular
filling; ST, stress test. Hypotension during DSE is defined as a reduction of
margins of the mitral valve. Mitral velocity profiles were systolic blood pressure .40 mm Hg during the test.
digitized from the modal velocity of the Doppler tracings.
The peak E (early rapid ventricular filling) and peak A
(atrial assisted filling) wave velocities were computed to
Adequate two-dimensional image recordings at rest andcalculate the E/A velocity ratio. Pulse-wave Doppler
during stress were obtained in all patients. Wall motionsignals were only measured at rest.
abnormalities at rest were present in 11 of the patients
Analytical methods of the HP and 11 of the patients of the HR group.
In both groups, the target heart rate was reached inBlood samples for determination of ANP were collected
in chilled tubes containing ethylenediaminetetraacetic 89% of patients. The frequency of the occurrence of
acid (EDTA) and aprotinin. Samples for measurement NWMAs between the two groups did not differ (Table 2).
of catecholamines were collected in chilled heparinized In nine HP and eight HR patients, CVP, plasma ANP
tubes containing gluthatione. All samples were immedi- and NOR, and E/A ratios were measured as well. CVP
ately centrifuged at 48C, and plasma was stored at 2808C. values were not low in any of the patients, and values
ANP was measured by a radioimmunoassay using a com- between the two groups did not differ. Because of
mercially available kit (Nichols Institute, Wijchen, The chronic renal failure, plasma ANP values were increased,
Netherlands). Plasma NOR was measured with fluoro- but values between the HP and HR groups were not
metric detection after HPLC separation. different. Values of plasma NOR were normal and did
not differ between the two groups (Table 1).
Statistical analysis
Early-rapid ventricular filling/atrial-assisted filling (E/A)
Hemodynamic variables are expressed as mean 6 sd. ratios were only measured at rest. The ratio was below
Cardiac output and stroke volume are expressed per 1.0 in seven of the nine HP patients and in five of the
body surface area. Total peripheral vascular resistance eight HR patients (P 5 0.06).
was calculated as mean arterial pressure divided by car- The resting values of blood pressure, heart rate, stroke
diac index. Differences in discrete variables between HR index, cardiac index, and total peripheral vascular resis-
and HP groups were analyzed by chi-square tests. Fur- tance for the two groups are given in Table 3. Most likely
thermore, a two-way analysis of variance was applied to related to the use of b-blockers, the heart rate was lower
evaluated changes in hemodynamic variables with in- and stroke volume was higher in the HR group, but the
creasing dobutamine dose (repeated measures), as well
resting cardiac output between the two groups did not
as differences in response between the HR and HP
differ. The responses of these hemodynamic variables
groups. For all tests, a P value of less than 0.05 was
to dobutamine for the two groups are summarized inconsidered to be statistically significant.
Table 3, whereas the hemodynamic responses of individ-
ual patients are depicted in Figure 1 A–D. In response
RESULTS to dobutamine, the stroke index decreased in the HP
group, whereas it did not change in the HR group. Be-The relevant clinical characteristics of the two groups
cause of these different responses in stroke index, theof patients are given in Table 1. The two groups did not
increase in cardiac index was considerably lower (P ,differ with respect to age, gender, duration of hemodialysis,
0.0001) in the HP group. Systolic blood pressure tendedcardiovascular history or cardiovascular disease, presence
of diabetes mellitus, and rest wall motion score (Table 1). to increase in the HR and to decrease in the HP group,
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Table 3. Hemodynamic characteristics of hypotension-prone (HP) and hypotension resistant (HR) patients during dobutamine
stress echocardiography
Rest HP Rest HR Low HP Low HR Peak HP Peak HR P1 P2
Heart rate bpm 76613 69 612 92 622 81 618 126617 130 619 ,0.0001 0.021
SBP mm Hg 135628 147 622 137 634 150 631 127 639 153 637 0.627 0.152
MAP mm Hg 94615 106616 97 620 104619 89 625 108626 0.761 0.089
DBP mm Hg 73613 85 614 76 618 81 614 71 620 85 623 0.820 0.103
TPRI u 2.2860.05 2.26 60.05 2.24 60.01 1.91 60.06 1.75 60.06 1.36 60.05 ,0.0001 0.124
SI ml/m2 3369 39 69 31 69 41 612 26 610 36 613 ,0.0001 0.081
CI liter/min/m2 2.461.1 2.8 61.2 2.8 61.7 3.4 61.8 3.2 62.6 5.1 63.3 ,0.0001 0.001
Abbreviations are: P1, difference during dobutamine infusion (rest-low-peak); P2, difference in response between HP and HR patients during respectively low and
peak dobutamine stress; SBP, systolic blood pressure; MAP, mean arterial pressure; DBP, diastolic blood pressure; TRPI, author please insert; SI, stroke index; CI,
cardiac index.
Fig. 1 A–D. Hemodynamic responses of indi-
vidual patients during dobutamine stress echo-
cardiography. The dotted lines represent pa-
tients with beta blocker therapy.
but there was no significant difference between the two Volume status is among one of the most important
groups (P 5 0.627). determinants for allowing stroke index and cardiac index
to increase in response to increasing doses of dobut-
amine. To ascertain that patients were studied in a vol-DISCUSSION
ume-repleted state, DSE was always performed one day
In this study, DSE was applied to evaluate cardiac before the next hemodialysis session. CVP just prior to
contractile reserve and the presence of myocardial ische-
the DSE was measured in approximately 50% of the
mia in HP and HR hemodialysis patients. Because of
patients. In these patients, CVP was relatively high, fur-the high incidence of previous myocardial infarction, wall
ther confirming that the patients were indeed not volumemotion abnormalities at rest were present in a large
depleted.proportion of both HP and HR patients. Dobutamine-
Left ventricular hypertrophy and uremic myocardialinduced ischemia, as defined by NWMAs, was observed
fibrosis are commonly present in hemodialysis patientsin only three of the HR and four of the HP patients, but
[2, 4, 12, 13]. These abnormalities impair ventricular re-compared with the HR patients, the myocardial contrac-
laxation and hence diastolic filling, resulting in a decreasetile reserve (increase in stroke index in response to do-
in cardiac output. At this time, we cannot rule out thatbutamine) was impaired in a considerably larger propor-
these abnormalities were more advanced in the HP pa-tion of the HP than HR patients. As a consequence of this
tients. A greater E/A velocity ratio in HP than in HRreduced myocardial contractile reserve, the dobutamine-
patients, as a reflection of diastolic dysfunction, has beeninduced maximal increase in cardiac index was much
lower in the HP patients. reported previously [14]. In this study, no difference in
Fig. 1. (Continued)
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Fig. 2. Scheme of proposed pathophysiologi-
cal mechanism of hemodialysis-induced hypo-
tension.
the E/A velocity ratio, although abnormal in almost all the sympathetic nervous system does not lead to an ap-
patients, between the two groups could be detected. propriate rise in cardiac output to maintain blood pres-
Dysfunction of cardiac b-adrenergic receptors could sure, further sympathetic discharge is likely to occur.
also explain the diminished myocardial responsiveness Eventually, because of exhaustion, the autonomic ner-
to dobutamine in the HP patients. High circulating levels vous system is no longer capable of maintaining this high
of NOR and epinephrine have been reported in patients level of sympathetic tone, and blood pressure will fall.
susceptible to development of hypotension during hemo- The cause of hemodialysis-induced hypotension in this
dialysis [15, 16]. This high sympatho-adrenergic state was situation is not primarily a consequence of failure of the
associated with a down-regulation of platelet a2- and autonomic nervous system but is the consequence of
lymphocyte b2-adrenoceptors, as well as a decreased in- diminished myocardial responsiveness or myocardial
tracellular cAMP generation after isoproterenol stimula- contractile reserve (Fig. 2). This hypothesis fits well with
tion [17]. In this study, no difference in plasma concentra- the observations of Zocalli et al, showing that tachycar-
tions of NOR between HP and HR patients was present. dia and not bradycardia is the predominant hemody-
It should be stressed that the concentrations of NOR namic response to hypotension during hemodialyis [18].
were not measured during the hemodialysis sessions but
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